Skip to content
HowShorted

Dianthus Therapeutics, Inc. short interest in 2023

In 2023, Dianthus Therapeutics, Inc.'s disclosed short interest ran from 1.01% of shares outstanding on 13 Jan 2023 to 0.31% on 29 Dec 2023, a change of -0.70 percentage points. The year's high was 1.96% on 31 Mar 2023 and its low 0.13% on 15 Nov 2023, averaging 0.78% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.33 days on 28 Apr 2023. Full history: Dianthus Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Dianthus Therapeutics, Inc. in 2023

2023 in figures

Start of year
1.01% (13 Jan 2023)
End of year
0.31% (29 Dec 2023)
Change
-0.70 pp
High
1.96% (31 Mar 2023)
Low
0.13% (15 Nov 2023)
Average
0.78%
Highest days to cover
6.33 (28 Apr 2023)
SEC filings marked
6

Every report in 2023

Dianthus Therapeutics, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20231.01%1.00
31 Jan 20230.69%1.00
31 Mar 20231.96%4.61results (8-K), 10-K filed
14 Apr 20231.76%4.09
28 Apr 20231.53%6.33
15 May 20230.67%1.0010-Q filed
31 May 20230.82%1.23
15 Jun 20230.88%1.25
30 Jun 20230.93%1.42
14 Jul 20230.65%1.80
31 Jul 20230.47%1.00
15 Aug 20230.63%1.4510-Q filed
31 Aug 20230.43%1.37
15 Nov 20230.13%1.2010-Q filed, results (8-K)
30 Nov 20230.13%1.34
15 Dec 20230.18%1.04
29 Dec 20230.31%1.09

See also: Dianthus Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.